WFM
LFCR icon

Wilmington Funds Management’s Lifecore Biomedical LFCR Stock Holding History

Wilmington Funds Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$279K Hold
22,370
– – 0.03% 560
2014
Q1 		$250K Sell
22,370
-6,896
-24% -$75.6K 0.03% 593
2013
Q4 		$355K Sell
29,266
-4,461
-13% -$53.3K 0.04% 501
2013
Q3 		$411K Sell
33,727
-1,220
-3% -$17K 0.04% 435
2013
Q2 		$462K Buy
+34,947
New +$483K 0.04% 398

Other funds holding LFCR

GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $1.03B AUM 20.67% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
KG
Killen Group Berwyn, Pennsylvania $866M AUM 0.25% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wilmington Funds Management's LFCR Position: Q2 2014 in Review

Wilmington Funds Management held its Lifecore Biomedical (LFCR) position steady in Q2 2014 at 22,370 shares worth $279K. The position accounts for 0.03% of the portfolio, ranked #560.

Wilmington Funds Management first reported a position in LFCR in Q2 2013 and has held it in 5 quarters since. The position peaked at $462K in Q2 2013. 101 funds tracked by Wall St. Rank hold LFCR as of Q2 2014.

  • Wilmington Funds Management held 22,370 shares of Lifecore Biomedical worth $279K as of Q2 2014.
  • Wilmington Funds Management left its Lifecore Biomedical share count unchanged in Q2 2014.
  • Lifecore Biomedical made up 0.03% of Wilmington Funds Management's portfolio in Q2 2014, its #560 holding.
  • Wilmington Funds Management first reported a position in Lifecore Biomedical in Q2 2013 and has held it in 5 quarters since.
  • Wilmington Funds Management's Lifecore Biomedical position peaked at $462K in Q2 2013.
  • 101 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.